When was the Tavalisse (fostamatinib) patent litigation resolution date for Rigel Pharmaceuticals?
The provided information does not include any details about Tavalisse patent litigation, a settlement, or a specific resolution date for Rigel Pharmaceuticals.
What litigation was involved (and how do I find the resolution date)?
To identify a “resolution date,” you typically need one of the following from a reliable legal or regulatory source:
- The specific case caption (plaintiff vs. defendant), court, and docket number
- The event that ended the litigation (settlement agreement, dismissal, consent judgment, or final judgment)
- The date of the docket event (often shown in court dockets or legal news summaries)
Where to check for the actual date
The resolution date is usually most clearly verified via:
- The relevant court docket entry (date-stamped)
- A settlement announcement tied to a specific case
- Regulatory exclusivity or litigation updates that reference the case outcome
If you meant a particular “patent” (which one?)
“Patent litigation” can refer to different patents or different defendants, each with its own timeline. If you share any of the following, I can narrow down what resolution date applies:
- the patent number (or application number)
- the name of the filing company/ANDA or biosimilar partner involved
- the court/jurisdiction (e.g., U.S. District Court for which district)
- the docket number or a link to the litigation page you’re using
Sources
No sources were provided that contain the Tavalisse patent litigation resolution date for Rigel Pharmaceuticals.